Page last updated: 2024-11-07

calvatic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Calvatic acid is a natural product with a unique structure that has drawn attention for its potential medicinal properties. It has been isolated from the fruiting bodies of various fungi, including *Calvatia gigantea*, the giant puffball mushroom. Research on calvatic acid is still ongoing, and its exact mechanisms of action and therapeutic potential are being explored. Studies have shown it to exhibit antimicrobial and anti-inflammatory activities, making it a promising candidate for drug development. The compound's synthesis remains challenging, with scientists investigating various approaches to obtain it efficiently. The complexity of its structure and its potential therapeutic benefits drive ongoing research into its isolation, synthesis, and pharmacological properties.'

calvatic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID99679
CHEMBL ID131824
MeSH IDM0055301

Synonyms (15)

Synonym
nsc264713
nsc-264713
calvatic acid
54723-08-9
benzoic acid, 4-(cyano-nno-azoxy)-
NCI60_002121
p-carboxyphenylazoxycyanide
CHEMBL131824
(4-carboxyphenyl)-cyanoimino-oxidoazanium
AKOS006276191
LDRFVNKBORCKQS-UHFFFAOYSA-N
4-carboxy-n-(cyanoimino)benzen-1-imine oxide
4-carboxy-n-(cyanoimino)benzen-1-imineoxide
EN300-300167
AKOS040734763

Research Excerpts

Overview

Calvatic acid is a new antibiotic with both a carboxylic group and an azoxy function in the benzene ring.

ExcerptReferenceRelevance
"Calvatic acid is a new antibiotic with both a carboxylic group and an azoxy function in the benzene ring. "( Some biological effects of calvatic acid and its analog on isolated hepatocytes.
Chiarpotto, E; Gabriel, L; Gadoni, E; Miglietta, A; Olivero, A, 1987
)
2.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID88245Minimal concentration needed to inhibit 50% of Helicobacter pylori strain2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
AID88248Minimal concentration needed to inhibit 90% of Helicobacter pylori strain2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
AID87947Inhibitory activity was determined against NCTC-11637 strain of Helicobacter pylori2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
AID87949Minimal concentration needed to inhibitH. pylori strain2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
AID87946Inhibitory activity was determined against 102R strain of Helicobacter pylori2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's4 (44.44)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.92 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]